Heranba Industries Ltd
₹152.17
+2.97 (1.99%)
Fri, 06 Nov 2026, 09:36 pm
Heranba Industries News
Heranba CFO Pravin Shetty resigns effective Dec 2026
Heranba Industries CFO Pravin Shetty resigned citing personal commitments. He will serve until Dec 31, 2026, to ensure smooth transition and complete consortium funding.
26 Oct 2026
companies
Heranba Industries concludes 34th AGM
Heranba Industries held its 34th AGM on September 28, 2026, via video conferencing. Shareholders approved audited FY26 financials and re-appointed key directors including the Chairman and MD.
28 Sept 2026
companies
Heranba Industries VP Procurement resigns
Sunil Singh resigns as Vice President - Procurement at Heranba Industries Ltd effective July 31, 2026.
21 Jul 2026
companies
Heranba Industries VP R&D resigns
Dr. Sunil Kumar resigns as Vice President - R&D of Heranba Industries effective July 31, 2026.
20 Jul 2026
companies
Heranba Industries: IBC Application Withdrawn, Matter Settled
Haresh Petrochem has withdrawn its application under the Insolvency and Bankruptcy Code against Heranba Industries, with the matter settled and no CIRP initiated.
10 Jun 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo